Symmetry Medical Closes $200 Million Credit Facility

WARSAW, Ind., Nov. 4, 2010 /PRNewswire/ — Symmetry Medical Inc. (NYSE: SMA), a

leading independent provider of products to the global orthopaedic device
industry and other medical markets, announced today that it has entered into a
$200 million senior secured revolving credit facility, effective November 3,
2010. The credit facility includes an “accordion feature” that permits expansion
of the borrowing capacity up to $300 million. The credit facility has a term of
five years.

Initial borrowings of approximately $89 million under the credit facility were
used to retire existing debt, including the existing term loans and revolving
credit facility, due in June 2011. The balance of the facility is available for
general corporate and working capital requirements, international expansion and
permitted acquisitions.

The new credit facility is priced at LIBOR plus an applicable percentage,
ranging from 175 basis points to 275 basis points, based on the Company’s
leverage ratio.

J.P. Morgan Securities LLC and Wells Fargo Bank Securities, LLC acted as Joint
Lead Arrangers and Joint Bookrunners for the credit facility and Periculum
Capital Company, LLC served as placement agent. JPMorgan Chase Bank, N.A. was
Administrative Agent and Wells Fargo Bank, National Association was Syndication
Agent. Bank of America, N.A., Fifth Third Bank and PNC Bank, National
Association served as Co-Documentation Agents. Other participating lenders
include The Northern Trust Company and U.S. Bank National Association.

Brian Moore, President and Chief Executive Officer of Symmetry Medical, stated,
“We are very pleased with the outstanding support received from our new banking
group as they see us as a good investment. The rates and terms of this agreement
are much better than what we expected earlier this year and we are looking
forward to utilizing this expanded capacity to drive both organic growth as well
as reviewing strategic acquisitions to drive increased shareholder value.”

Mr. Moore went on to say, “I would also like to thank Fred Hite, Chief Financial
Officer of Symmetry Medical, and David Milne, General Counsel & Senior Vice
President of Human Resources for their outstanding leadership in completing this
very significant agreement for our Company.”

About Symmetry Medical Inc.

Symmetry Medical Inc. is a leading independent provider of implants and related
instruments and cases to the orthopaedic device industry. The Company also
designs, develops and produces these products for companies in other segments of
the medical device market, including arthroscopy, dental, laparoscopy,
osteobiologic and endoscopy sectors and provides limited specialized products
and services to non-healthcare markets, such as the aerospace market.

Forward-Looking Statements

Statements in the press release regarding Symmetry Medical Inc.’s business,
which are not historical facts, may be “forward-looking statements” that involve
risks and uncertainties, within the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Forward-looking statements are
predictive in nature and are frequently identified by the use of terms such as
“may,” “will,” “should,” “expect,” “believe,” “estimate,” “intend,” and similar
words indicating possible future expectations, events or actions. Such
predictive statements are not guarantees of future performance, and actual
results could differ materially from our current expectations. Certain factors
that could cause actual results to differ include: the loss of one or more
customers; the development of new products or product innovations by our
competitors; product liability; changes in management; changes in conditions
effecting the economy, orthopaedic device manufacturers or the medical device
industry generally; and changes in government regulation of medical devices and
third-party reimbursement practices. We refer you to the “Risk Factors” and
“Forward Looking Statements” sections in the Company’s most recent Annual Report
on Form 10-K filed with the Securities and Exchange Commission as well as the
Company’s other filings with the SEC, which are available on the SEC’s Web site
at www.sec.gov.

Contact: Investors:
Symmetry Medical Inc. The Ruth Group
Fred L. Hite Nick Laudico/Zack Kubow
Senior Vice President (646) 536-7030/7020
Chief Financial Officer nlaudico@theruthgroup.com
(574) 371-2218 zkubow@theruthgroup.com

Media:
The Ruth Group
Jason Rando
(646) 536-7025
jrando@theruthgroup.com

SOURCE Symmetry Medical Inc.